Search
inhibitor of nuclear factor kappa-B kinase subunit beta; I-kappa-B-kinase beta; IkBKB; IKK-beta; IKK-B; I-kappa-B kinase 2; IKK2; nuclear factor NF-kappa-B inhibitor kinase beta; NFKBIKB (IKBKB, IKKB)
Function:
- component of the IKK complex in the conventional pathway of NF-kappa-B activation
- phosphorylates inhibitors of NF-kappa-B thus leading to dissociation of the inhibitor/NF-kappa-B complex & ultimately the degradation of the inhibitor
- IKK-beta is required for TNF-alpha induction of NF-kappa B
- also phosphorylates NCOA3
- part of a complex composed of NCOA2, NCOA3, CHUK/IKKA, IKBKB, IKBKG & CREBBP
- part of a 70-90 kD complex at least consisting of CHUK/IKKA, IKBKB, NFKBIA, RELA, IKBKAP & MAP3K14
- interacts with SQSTM1 through PRKCZ or PRKCI
- forms an NGF-induced complex with IKBKB, PRKCI & TRAF6
- may interact with MAVS/IPS1
- interacts with NALP2
- interacts with TICAM1
- interacts with Yersinia yopJ
- interacts with FAF1; the interaction disrupts the IKK complex formation
- interacts with ATM
- interacts with NIK
- part of a ternary complex consisting of TANK, IKBKB & IKBKG
- interacts with NIBP; the interaction is direct upon cytokine stimulation
- phosphorylated on Ser-177 & Ser-181 by MEKK1 &/or MAP3K14/NIK; which enhances activity
- once activated, autophosphorylates on the C-terminal Ser cluster which decreases activity & prevents prolonged activation of the inflammatory response
- ubiquitination on Ser-163 modulates phosphorylation on C-terminal Ser
Structure:
- can exist as homodimer or heterodimer [2]
- belongs to the protein kinase superfamily, Ser/Thr protein kinase family, I-kappa-B kinase subfamily
- contains canonical MAP kinase kinase activation loop motif SXXXS
- contains 1 protein kinase domain
Compartment: cytoplasm
Expression:
- highly expressed in heart, placenta, skeletal muscle, kidney, pancreas, spleen, thymus, prostate, testis & peripheral blood
Pathology:
- Yersinia yopJ may acetylate Ser/Thr residues, preventing phosphorylation & activation, which blocks the I-kappa-B signaling pathway
- implicated in aspirin-sensitive insulin resistance; aspirin or sodium salicylate attenuates IKK-beta mediated insulin resistance
Interactions
molecular events
General
serine/threonine kinase
Properties
SIZE: entity length = 756 aa
MW = 87 kD
COMPARTMENT: cytoplasm
STATE: active state
MOTIF: kinase domain
SITE: 15-300
MOTIF: ATP-binding site
NAME: ATP-binding site
SITE: 21-29
Thr phosphorylation site {T23}
ATP-binding site
NAME: ATP-binding site
SITE: 44-44
aspartate residue {D145}
Ser phosphorylation site {S177}
Ser phosphorylation site {S181}
leucine zipper
SITE: 458-479
FOR-BINDING-VIA: leucine zipper
Ser phosphorylation site {S670}
Ser phosphorylation site {S672}
Ser phosphorylation site {S675}
Ser phosphorylation site {S682}
Ser phosphorylation site {S689}
Ser phosphorylation site {S692}
Ser phosphorylation site {S695}
Ser phosphorylation site {S697}
Ser phosphorylation site {S705}
Ser phosphorylation site {S733}
binding site
SITE: 737-742
FOR-BINDING-OF: NF-kappa-B essential modulator
MOTIF: Ser phosphorylation site {S740}
Ser phosphorylation site {S750}
Database Correlations
OMIM 603258
UniProt O14920
PFAM correlations
Entrez Gene 3551
KEGG correlations
ENZYME 2.7.11.10
References
- Mercurio F et al
IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential
for NF-kappaB activation.
Science 278:860-6, 1997
PMID: 9346484
- Woronicz JD et al.
IkappaB kinase-beta: NF-kappaB activation and complex
formation with IkappaB kinase-alpha and NIK.
Science 278:866-9,
- Peters RT et al
IKKepsilon is part of a novel PMA-inducible IkappaB kinase
complex.
Molecular Cell 5:513-22, 2000
PMID: 10882136
- Journal Watch 21(19):157, 2001
Yuan M et al
Reversal of obesity- and diet-induced insulin resistance with
salicylates or targeted disruption of Ikkbeta.
Science 293:1673, 2001
PMID: 11533494
- UniProt :accession O14920
- SeattleSNPs
http://pga.gs.washington.edu/data/ikbkb/
Component-of
IkB kinase complex